{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:00:40Z","timestamp":1784934040317,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Grange syndrome is an ultra-rare autosomal recessive disorder caused by biallelic loss-of-function variants in the\n                      <jats:italic>YY1AP1<\/jats:italic>\n                      gene. It is clinically characterized by multisystem involvement, including vascular stenosis, brachysyndactyly, osteopenia, cardiac anomalies, and neurodevelopmental delay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our case was followed up in the Child and Adolescent Psychiatry clinic with the diagnosis of intellectual disability. Whole-exome sequencing (WES) was performed, and Sanger sequencing was used to confirm the identified variant and conduct familial segregation analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We report a 17-year-old Turkish female who presented with academic failure, speech delay, dysarthria, facial dysmorphism, and surgically corrected hand syndactyly. Notably, she exhibited no clinical signs of vascular stenosis or hypertension at the time of diagnosis. A novel compound heterozygous variant combination in\n                      <jats:italic>YY1AP1<\/jats:italic>\n                      (NM_139119.3) was identified: c.1489_1492del (p.Glu636ProfsTer13), previously reported as pathogenic, and c.1637_1638del (p.Pro546ArgfsTer26), a novel frameshift variant. These variants were maternally and paternally inherited, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This is the first reported case of Grange syndrome diagnosed based on neurodevelopmental and dysmorphic findings before the onset of vascular or hypertensive symptoms. Our findings highlight the importance of considering\n                      <jats:italic>YY1AP1<\/jats:italic>\n                      -related pathology in the differential diagnosis of intellectual disability and syndactyly, even in the absence of vascular features. Early genetic diagnosis enables clinical surveillance for life-threatening complications associated with this syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s10038-026-01471-0","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:33:07Z","timestamp":1774488787000},"page":"485-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel compound heterozygous YY1AP1 variant in Grange syndrome: importance of early signs in preventing life-threatening vascular complications"],"prefix":"10.1038","volume":"71","author":[{"given":"Gul","family":"Unsel-Bolat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8102-908X","authenticated-orcid":false,"given":"Neslihan","family":"Tezcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilan","family":"Gen\u00e7-Akda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5218-7880","authenticated-orcid":false,"given":"Hamide Bet\u00fcl","family":"Gerik-Celebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alperen","family":"Tezcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi","family":"Bolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"1471_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2016.11.008","volume":"100","author":"DC Guo","year":"2017","unstructured":"Guo DC, Duan XY, Regalado ES, Mellor-Crummey L, Kwartler CS, Kim D, et al. Loss-of-function mutations in YY1AP1 lead to Grange syndrome and a fibromuscular dysplasia-like vascular disease. Am J Hum Genet. 2017;100:21\u201330.","journal-title":"Am J Hum Genet"},{"key":"1471_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/(SICI)1096-8628(19980217)75:5<469::AID-AJMG4>3.0.CO;2-I","volume":"75","author":"DK Grange","year":"1998","unstructured":"Grange DK, Balfour IC, Chen SC, Wood EG. Familial syndrome of progressive arterial occlusive disease consistent with fibromuscular dysplasia, hypertension, congenital cardiac defects, bone fragility, brachysyndactyly, and learning disabilities. Am J Med Genet. 1998;75:469\u201380.","journal-title":"Am J Med Genet"},{"key":"1471_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000527785","volume":"14","author":"T Karakaya","year":"2023","unstructured":"Karakaya T, Turkyilmaz A, Eris D, Kaya M, Oksuz K, Eryigit MA, et al. The new youngest case of Grange syndrome with a novel biallelic pathogenic variant in YY1AP1. Mol Syndromol. 2023;14:239\u201345.","journal-title":"Mol Syndromol"},{"key":"1471_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-021-00328-1","volume":"15","author":"V Raggio","year":"2021","unstructured":"Raggio V, Dell\u2019Oca N, Simoes C, Tapi\u00e9 A, Medici C, Costa G, et al. Whole genome sequencing reveals a frameshift mutation and a large deletion in YY1AP1 in a girl with a panvascular artery disease. Hum Genomics. 2021;15:28.","journal-title":"Hum Genomics"},{"key":"1471_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ajmg.a.60700","volume":"179","author":"M Rath","year":"2019","unstructured":"Rath M, Spiegler S, Strom TM, Trenkler J, Kroisel PM, Felbor U. Identification of pathogenic YY1AP1 splice variants in siblings with Grange syndrome by whole exome sequencing. Am J Med Genet A. 2019;179:295\u20139.","journal-title":"Am J Med Genet A"},{"key":"1471_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s10038-019-0626-0","volume":"64","author":"K Saida","year":"2019","unstructured":"Saida K, Kim CA, Ceroni JRM, Bertola DR, Honjo RS, Mitsuhashi S, et al. Hemorrhagic stroke and renovascular hypertension with Grange syndrome arising from a novel pathogenic variant in YY1AP1. J Hum Genet. 2019;64:885\u201390.","journal-title":"J Hum Genet"},{"key":"1471_CR7","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1002\/ajmg.a.63394","volume":"191","author":"E Viora-Dupont","year":"2023","unstructured":"Viora-Dupont E, Denomm\u00e9-Pichon A, Chevarin M, Patat O, Willems M, Bourgon N, et al. Identification of the first homozygous intragenic deletion in the YY1AP1 gene in a consanguineous family: New insights into the phenotypic variability associated with Grange syndrome. Am J Med Genet A. 2023;191:2728\u201335.","journal-title":"Am J Med Genet A"},{"key":"1471_CR8","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1002\/ajmg.a.35593","volume":"158a","author":"I Volonghi","year":"2012","unstructured":"Volonghi I, Frigerio M, Mardighian D, Gasparotti R, Del Zotto E, Giossi A, et al. Grange syndrome: an identifiable cause of stroke in young adults. Am J Med Genet A. 2012;158a:2894\u20138.","journal-title":"Am J Med Genet A"},{"key":"1471_CR9","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1002\/ajmg.a.31125","volume":"140","author":"R Wallerstein","year":"2006","unstructured":"Wallerstein R, Augustyn AM, Wallerstein D, Elton L, Tejeiro B, Johnson V, et al. A new case of Grange syndrome without cardiac findings. Am J Med Genet A. 2006;140:1316\u201320.","journal-title":"Am J Med Genet A"},{"key":"1471_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1138>3.0.CO;2-R","volume":"99","author":"S Weymann","year":"2001","unstructured":"Weymann S, Yonekawa Y, Khan N, Martin E, Heppner FL, Schinzel A, et al. Severe arterial occlusive disorder and brachysyndactyly in a boy: a further case of Grange syndrome?. Am J Med Genet. 2001;99:190\u20135.","journal-title":"Am J Med Genet"},{"key":"1471_CR11","doi-asserted-by":"crossref","unstructured":"Alsadiqi A, Bamahmud A, Altaf L, Abumansour I, Alsheikh I, Zia Z, et al. The clinical spectrum of Grange syndrome: a case report of a novel variant and literature review. Med Rep. 2026;16:100415.","DOI":"10.1016\/j.hmedic.2026.100415"},{"key":"1471_CR12","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1002\/ajmg.a.61379","volume":"179","author":"IV Ciuffetelli Alamo","year":"2019","unstructured":"Ciuffetelli Alamo IV, Kwartler CS, Regalado ER, Afifi RO, Parkash S, Rideout A, et al. Grange syndrome due to homozygous YY1AP1 missense rare variants. Am J Med Genet A. 2019;179:2500\u20135.","journal-title":"Am J Med Genet A"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01471-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01471-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01471-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:02:36Z","timestamp":1784930556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01471-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1471"],"URL":"https:\/\/doi.org\/10.1038\/s10038-026-01471-0","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}